Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11901-014-0227-5 http://scihub22266oqcxt.onion/10.1007/s11901-014-0227-5 C4066391!4066391!24977111     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Hepatol+Rep 2014 ; 13 (2): 151-8 Nephropedia Template TP {{tp|p=24977111|t=2014. Hepatic steatosis and steatohepatitis: Are they really two distinct entities?|pdf=|usr=}}{{24977111}} gab.com Text Hepatic steatosis and steatohepatitis: Are they really two distinct entities JO: Curr Hepatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=24977111 #FOAvip Non-alcoholic fatty liver disease affects nearly 30% of Americans. A histopathological spectrum exists from simple steatosis to NASH which may progress to cirrhosis and HCC. NASH is currently the third most common indication for liver transplant with increasing incidence. Steatosis can be considered the hepatic manifestation of the metabolic syndrome as insulin resistance is a major risk factor for its development. While liver biopsy is the gold standard for diagnosis, non-invasive methods are currently being developed to appropriately determine who needs histologic evaluation. Management focuses on mitigation of risk factors, since targeted therapies to halt progression of fibrosis have not been validated. Simple steatosis does not affect overall survival, but NASH conveys increased mortality. Because of this, non-invasive strategies to diagnose patients and management algorithms are needed. This review supports the definitions of simple steatosis and NASH as two distinct entities based on pathophysiology, diagnosis, management, and prognosis. Twit Text FOAVip Hepatic steatosis and steatohepatitis: Are they really two distinct entities ????Curr Hepatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=24977111 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24977111 #FOAvip English Wikipedia <ref>{{Cite pmid|24977111}}</ref> Hepatic steatosis and steatohepatitis: Are they really two distinct entities? #MMPMID24977111 Fielding CM; Angulo P Curr Hepatol Rep 2014[Jun]; 13 (2): 151-8 PMID24977111show ga Non-alcoholic fatty liver disease affects nearly 30% of Americans. A histopathological spectrum exists from simple steatosis to NASH which may progress to cirrhosis and HCC. NASH is currently the third most common indication for liver transplant with increasing incidence. Steatosis can be considered the hepatic manifestation of the metabolic syndrome as insulin resistance is a major risk factor for its development. While liver biopsy is the gold standard for diagnosis, non-invasive methods are currently being developed to appropriately determine who needs histologic evaluation. Management focuses on mitigation of risk factors, since targeted therapies to halt progression of fibrosis have not been validated. Simple steatosis does not affect overall survival, but NASH conveys increased mortality. Because of this, non-invasive strategies to diagnose patients and management algorithms are needed. This review supports the definitions of simple steatosis and NASH as two distinct entities based on pathophysiology, diagnosis, management, and prognosis. äHepatic steatosis and steatohepatitis: Are they really two distinct en(epmc).pdf DeepDyve Pubget Overpricing